Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients

Trial Profile

Intravenous Iron Supplement for Iron Deficiency in Cardiac Transplant Recipients

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 20 Sep 2018

At a glance

  • Drugs Iron isomaltoside 1000 (Primary)
  • Indications Iron deficiency anaemia
  • Focus Therapeutic Use
  • Acronyms IronIC
  • Most Recent Events

    • 17 Sep 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top